UNC Rex Cancer Center — Raleigh, North Carolina

UNC Rex Cancer Center is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

UNC Rex Cancer Center has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Sponsors: Dana-Farber Cancer Institute, National Cancer Institute (NCI), RTOG Foundation, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Rex Cancer Center?

UNC Rex Cancer Center has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Rex Cancer Center conducted?

UNC Rex Cancer Center has 5 clinical trials on record, with 4 currently active. Their work covers HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer.

Is UNC Rex Cancer Center accredited by Crixeo Health?

Yes — UNC Rex Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UNC Rex Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.